Navigation Links
Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
Date:11/5/2009

SAN DIEGO, Nov. 5 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products announced the addition of customized Formulation Development to the company's platform of services, which will be overseen by the newly appointed Dr. James Matsuura, Director of Formulation Development. This investment in an experienced team of formulation and analytical scientists, along with new laboratory facilities and state-of-the-art equipment, enhances and complements Althea's existing expertise and capabilities in cGMP biologics manufacturing and aseptic filling of injectable products, and completes the full integration of development and manufacturing services available for clients from early-stage development through commercial supply.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

The new formulation laboratories are an expansion to the clinical manufacturing facility located on the San Diego campus and are further supported by the analytical expertise of Windrose Analytica, which was acquired by Althea earlier this year. "The addition of our new formulation development laboratories is the perfect complement to our advanced protein and peptide analytical capabilities, and will allow us to bring our clients' products into the clinic with unmatched speed, efficiency and effectiveness," noted Dr. Alan Herman, Vice President of Product Development & Chief Scientific Officer.

"We are delighted to have Dr. James Matsuura join Althea. His many years of experience bring added value to clients in helping them with the complexities of developing protein formulations for both clinical trials and product launch in our new commercial manufacturing facility," commented Dr. Shabbir Anik, Althea President and Chief Executive Officer, on the appointment of Dr. James Matsuura as Director of Formulation Development.

Althea's formulation development scientists are experienced in developing both liquid and lyophilized formulations, to ensure that a stable product is delivered to the clinical site and the patient. The expanded facilities include a new development lyophilizer, which allows the group to optimize lyophilization cycles for products requiring enhanced stability. The new formulation laboratory and staff, operating closely with the analytical development group, complete Althea's product development group and enable Althea to support clients with critical development steps, as well as the manufacture of API and finished product.

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA, that provides the technical expertise and flexibility to successfully develop and manufacture clinical and commercial drug product for its clients. Althea offers cell banking, process development, cGMP protein & plasmid production, formulation development, analytical development, aseptic filling, and lyophilization services. For more information, visit www.altheatech.com.

SOURCE Althea Technologies, Inc.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census
2. Competitive Technologies Selects RF
3. Binder as Public Relations Agency of Record
4. Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
5. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
6. Leading Event for People With Disabilities on November 6-8 Features Latest Technologies, Products, Services, and More
7. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
8. China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
9. Palatin Technologies to Present at 8th Annual BIO Investor Forum
10. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
11. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Calif. , Dec. 5, 2016 Sanovas, ... technology accelerator, announced today the launch of its wholly owned ... Logo - http://photos.prnewswire.com/prnh/20161202/445250LOGO   Logo - http://photos.prnewswire.com/prnh/20161202/445251LOGO ... ... There ...
(Date:12/5/2016)... 5, 2016  New research by the CVS ... and the U.S. Department of Health and Human ... and Response (ASPR), published online today in ... notifications encourage patients with chronic conditions to refill ... study also affirms that public-private partnerships can facilitate ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
Breaking Medicine Technology:
(Date:12/6/2016)... Vancouver, B.C., Canada (PRWEB) , ... December 06, ... ... Consultants (STC) announce the availability of the newly updated International Audit Protocol Consortium ... world use IAPC EHS audit protocols to understand the scope of their EHS ...
(Date:12/5/2016)... ... ... What: Shriners Hospitals for Children, with the help of Dimension Data, will bring ... monitor and web-enabled camera. Santa visits with children through Dimension Data’s program to connect ... is where the video connection to the North Pole will stream. Much like children ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... been featured in SuperbCrew magazine, a leading online tech news platform connecting technology ... now featured on SuperbCrew.com, explores the state of enterprise mobility security today, and ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of ... who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf ... for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his ...
Breaking Medicine News(10 mins):